European Union (EU) regulators have delayed a decision to give approval for Novavax’s (NVAX.O) variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.
The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.
Comments closedIreland’s Covid-19 vaccination programme prevented 16,000 deaths and hugely reduced hospital and intensive care admissions, according to a Health Service Executive study.
Comments closedEU lawmakers approved a report on lessons to take from COVID-19 on Wednesday (12 July). The text analysed the impact of the pandemic, evaluated EU and national health systems’ responses and set a roadmap for future health emergencies.
The European Parliament adopted the report “COVID-19 pandemic: Lessons learned and recommendations for the future” by 385 votes in favour, 193 against and 63 abstentions.
Comments closed